EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
This second European Federation of Neurological Societies Task Force aimed at updating the existing evidence about the pharmacological treatment of neuropathic pain since 2005.
Recommendations for the management of herpes zoster.
The results of controlled trials and the clinical experience of the authors support the use of acyclovir, brivudin (where available), famciclovir, and valacy Clovir as first-line antiviral therapy for the treatment of patients with HZ.
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
CBM was generally well tolerated, although more patients on CBM than placebo reported dizziness, dry mouth, and somnolence, and Cognitive side effects were limited to long-term memory storage.
AAN‐EFNS guidelines on trigeminal neuralgia management
- G. Cruccu, G. Gronseth, J. Zakrzewska
- Medicine, PsychologyEuropean Journal of Neurology
- 1 October 2008
Carbamazepine or oxcarbazepine should be offered as first‐line treatment for pain control and microvascular decompression may be considered over other surgical techniques to provide the longest duration of pain freedom in patients with TN.
EFNS guidelines on pharmacological treatment of neuropathic pain
Evaluated trials provide level A evidence for the efficacy of tricyclic antidepressants, gabapentin, pregabalin and opioids, with a large number of class I trials, followed by topical lidocaine and the newer antidepressants venlafaxine and duloxetine.
NeuPSIG guidelines on neuropathic pain assessment
Trigeminal neuralgia--pathophysiology, diagnosis and current treatment.
Modern neurosurgical treatment can be traced back to 1925 when the concept of vascular compression was introduced, however, it took over half a century before microvascular decompression (MVD) gained wide-spread acceptance as a treatment method.
European Academy of Neurology guideline on trigeminal neuralgia
The European Academy of Neurology asked an expert panel to develop recommendations for a series of questions that are essential for daily clinical management of patients with TN.
Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial
A grading system of definite, probable, and possible neuropathic pain is proposed, which includes the grade possible, which can only be regarded as a working hypothesis, and the grades probable and definite, which require confirmatory evidence from a neurologic examination.